Literature DB >> 11528529

A vascular connection to Alzheimer's disease.

J A Rhodin1, T Thomas.   

Abstract

Alzheimer"s disease (AD) is characterized by a progressive and debilitating dementia in elderly people. The causes of this disease are not known, but major risk factors include old age and a family history of dementia, Down"s syndrome, female gender, low level of education, and head injury. There is no known cure for Alzheimer"s disease. The disease is characterized by abnormal accumulation of amyloid-beta peptide and the protein Tau in the nerve cells and extracellular space of certain regions of the brain. Cerebral amyloid angiopathy is another marker for Alzheimer"s disease. In autopsies, small cerebral arterial blood vessels and capillaries show signs of inflammation, amyloid accumulations, and a focal breach of the blood-brain barrier. This review focuses on the results of recent investigations of vascular responses to infusion of amyloid-beta(1-40), the means of preventing vascular damage, using a live animal (rat) model, and the combination of intravital video recordings of the mesenteric microvascular bed with electron microscopic analyses of the same vascular segments. We propose that the cerebral vascular changes in patients with Alzheimer"s disease probably precede the neuronal damage and dementia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11528529     DOI: 10.1038/sj/mn/7800086

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  15 in total

Review 1.  Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms.

Authors:  Maike Krenz; Ronald J Korthuis
Journal:  J Mol Cell Cardiol       Date:  2011-10-23       Impact factor: 5.000

Review 2.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

3.  A super-resolution ultrasound method for brain vascular mapping.

Authors:  Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Med Phys       Date:  2013-11       Impact factor: 4.071

Review 4.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

5.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

6.  Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers.

Authors:  Francisco J Gonzalez-Velasquez; Joseph A Kotarek; Melissa A Moss
Journal:  J Neurochem       Date:  2008-09-16       Impact factor: 5.372

7.  Cardiovascular disease could be contained based on currently available data!

Authors:  Okom Nkili F C Ofodile
Journal:  Dose Response       Date:  2006-09-23       Impact factor: 2.658

8.  Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophen.

Authors:  Debjani Tripathy; Alma Sanchez; Xiangling Yin; Joseph Martinez; Paula Grammas
Journal:  Microvasc Res       Date:  2012-08-27       Impact factor: 3.514

9.  Vascular endothelial barrier dysfunction mediated by amyloid-beta proteins.

Authors:  Enika Nagababu; Peter V Usatyuk; Divya Enika; Viswanathan Natarajan; Joseph M Rifkind
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 10.  Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.

Authors:  Paula Grammas
Journal:  J Neuroinflammation       Date:  2011-03-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.